Benufutamab

Tax included
Benufutamab (GEN1029) is a death receptor 5 (DR5)-specific agonistic antibody. Benufutamab is a mixture of 2 noncompeting DR5-specific IgG1 antibodies, each with an E430G mutation in the Fc domain. Benufutamab has antitumor effects.
MedChemExpress 
HY-P99470

Data sheet

Size
Multiple sizes
Reactivity
TNF Receptor; Apoptosis
Application
Cancer-programmed cell death
CAS
2109730-69-8